EMEA-001978-PIP02-19

Key facts

Active substance
aprocitentan
Therapeutic area
Cardiovascular diseases
Decision number
P/0356/2019
PIP number
EMEA-001978-PIP02-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Idorsia Pharmaceuticals Deutschland GmbH

Tel. +41 588440000
E-mail: clinical-trials-disclosure@idorsia.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating